Wegovy vs Bydureon

Quick Facts

  • Type: GLP-1
  • FDA Approval: Wegovy (2021), Bydureon (2012)
  • Frequency: Once weekly

Weight Loss Data

  • Wegovy: 15-17% in 68 weeks
  • Bydureon: 2-4% in 24 weeks

Primary Uses

  • Weight Management
  • Obesity Treatment
  • Type 2 Diabetes

Medication Overview

Wegovy

GLP-1

Basic Information

  • Generic Name: semaglutide
  • Manufacturer: Novo Nordisk
  • FDA Approval: 2021

Key Benefits

  • Significant weight loss potential
  • Once-weekly dosing
  • Improved cardiovascular markers
  • Established safety profile

Bydureon

GLP-1

Basic Information

  • Generic Name: exenatide extended-release
  • Manufacturer: AstraZeneca
  • FDA Approval: 2012

Key Benefits

  • Once-weekly dosing
  • No dose titration needed
  • Steady medication levels
  • Established safety profile

Dosing Information

Dosing DetailsWegovyBydureon
Starting Dose0.25mg2mg
Maintenance Dose1mg to 1.7mg2mg
Maximum Dose2.4mg2mg
ScheduleInject once weekly on the same day each weekInject once weekly at any time of day
TitrationStart with 0.25mg, increase every 4 weeks through 0.5mg, 1mg, 1.7mg to reach 2.4mgNo titration required, fixed 2mg dose

Side Effects

Wegovy

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal Pain
  • Headache

Bydureon

  • Nausea
  • Diarrhea
  • Headache
  • Vomiting
  • Constipation
  • Injection Site Reactions

Practical Information

Wegovy

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 56 days
  • Needle Info: Comes with NovoFine® Plus needles

Insurance & Coverage

Variable coverage for weight management, often requires prior authorization

Clinical Results

  • Weight Loss: 15-17%
  • Study Duration: 68 weeks
  • Study: STEP clinical trial program

Bydureon

Storage & Handling

  • Storage: Refrigerate until use, do not freeze
  • Needle Info: Comes with needles in kit

Insurance & Coverage

Generally covered for diabetes treatment

Clinical Results

  • Weight Loss: 2-4%
  • Study Duration: 24 weeks
  • Study: DURATION clinical trials

Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.

ShotWise App Interface

Track Your GLP-1 Journey with ShotWise

Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.

Download ShotWise